Survey: Would You Still Recommend Drug-Eluting Stents?

September 11, 2006

Drug-eluting stents essentially eliminated short-term restenosis as a complication of coronary angioplasty, but suddenly the coated devices have come under a cloud for possible late term risks. This Medpage Today survey asks your opinion about the future use of drug-eluting stents. Additional Stent Coverage from ESC: Meta-Analyses Find Increased Death and MI with Cypher Stent Real World Trial Confirms Drug-Eluting Stents Better in Small Vessels Investigational Drug-Eluting Stent Superior to Taxus Drug-Eluting Stent Debate Develops Fever Pitch

Drug-eluting stents essentially eliminated short-term restenosis as a complication of coronary angioplasty, but suddenly the coated devices have come under a cloud for possible late-term risks.

Cardiologists attending the European Society of Cardiology/World Congress of Cardiology in Barcelona last week were shocked by meta-analyses data that raised serious questions about the long-term safety of the devices.

This Medpage Today survey asks for your opinion about whether you still have confidence in the elective use of drug-eluting stents.